Adam Segal discusses the Cybersecurity Act, China, and technology innovation in an interview with Evan Osnos.

Laurie Garrett says U.S. support for global efforts to combat HIV/AIDS, though likely not to receive any thank yous, is significant.

Efforts to vaccinate Pakistani children are in peril after the CIA's vaccine ploy to help capture Osama bin Laden, placing the entire region at risk of outbreaks, says CFR's Laurie Garrett.

CFR Senior Fellow Isobel Coleman speaks with Boris Weber, director of ICT4Gov at the World Bank Institute, on how technology is being leveraged to promote good governance and increased transparency in fragile states and emerging markets.

This was a meeting of the Civil Society, Markets, and Democracy Roundtable series.

Frank G. Klotz writes SpaceX is clearly a pioneer—but it's also a business. In this sense, the greatest challenges for the company may reside not in space but in the marketplace.

Secretary of State Hillary Clinton gave these remarks at the Global Health Summit in Oslo, Norway on June 1, 2012.

The White House released this strategy document, "Digital Government: Building a 21st Century Platform to Better Serve the American People" on May 23, 2012.

Laurie Garrett and Steven A. Cook discuss the threats of Avian flu and foot and mouth disease in Egypt.

The Asia-Pacific Economic Cooperation (APEC) released its TEL Strategic Action Plan: 2010 – 2015 at the 8th Ministerial Meeting on Telecommunications and Information Industry in Japan on October 30-31, 2010.

Ken Auletta writes that there are no walls between Stanford and Silicon Valley. Should there be?

SAP Co-Chief Executive Officer Bill McDermott shares his view on how SAP is dealing with the changing impact of technology on the global economy and on policymakers.

This meeting is part of the Corporate Program's CEO Speaker Series, which provides a forum for leading global CEOs to share their priorities and insights before a high-level audience of CFR members. The series aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership.

Michael W. Hodin states, "Now that the World Health Organization has stepped up and declared both Alzheimer's and aging populations as defining challenges of our era, it is time for our presidential candidates to also get serious and honest about health policy fit for this century's demographics truths."

CFR Senior Fellow Thomas J. Bollyky and the Center for Global Development's director of global health policy Amanda Glassman propose using an innovative incentive mechanism, Cash-on-Delivery (COD) Aid, to improve tobacco control in developing countries.

The World Health Organization has deemed "Aging and Health" the theme of this year's World Health Day, observed on April 4, recognizing its importance as a global issue. As the United States moves toward a new demographic landscape—by 2020 the number of Americans older than the traditional retirement age will have grown considerably—policy implications and innovation are likely to follow at home and abroad. Please join Michael Hodin, Robert Hormats, and Jane Shaw to discuss what is in store for a rapidly graying United States with a focus on the public and private sectors.

The Council of Europe's Convention on the Counterfeiting of Medical Products and Similar Crimes Involving Threats to Public Health was adopted on October 28, 2011.

Drawing on the lessons of the Information Technology Agreement, Matthew Slaughter calls for the elimination of international trade and investment barriers in energy industries.

Peter Orszag argues that Greece should raise tobacco taxes to provide much-needed revenue and reduce its sky-high smoking rate.

Benn Steil's Forbes op-ed takes a critical look at the economics behind the Obama Administration's free-contraception insurance mandate.

In 2010, U.S. President Barack Obama articulated his vision for the future of American space exploration, which included an eventual manned mission to Mars. Such an endeavor would surely cost hundreds of billions of dollars -- maybe even $1 trillion.

Peter Orszag explores the relationship between economic downturns and improvements in life expectancy.